Company / Operating Margin
Metagenomi Therapeutics, Inc. Operating Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-380.9%
FY2025
5-year range
-380.9% / -175.4%
FY2024-FY2025
Trend
-117.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-380.9% in FY2025.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 117.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.90 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -380.9% | -117.2% |
| FY2024 | -175.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026